Citations

Clear

4 citation(s) found for "Gian, Richard Kinh".

Updates on LI‐RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI
Patel, Richa , Aslam, Anum , Parikh, Neehar D. , Mervak, Benjamin M. , Mubarak, Eman , Higgins, Lily, Lala, Kayli, Conner, Jack F., Khaykin, Valerie , Bashir, Mustafa R. , Gian, Richard Kinh , Burke, Lauren M. , Smith, Elainea N. , Shampain, Kimberly L. , Owen, Dawn , Do, Richard Kinh Gian , Mendiratta-Lala, Mishal , Parikh, Neehar D , Kim, Charles

Mayo Clinic

Journal of Magnetic Resonance Imaging | March 6, 2023 | Volume: 57 | Issue: 6 | Pages: 1641-1654

10.1002/jmri.28659 | PMID 36872608 Get It

As the incidence of hepatocellular carcinoma (HCC) and subsequent treatments with liver‐directed therapies rise, the complexity of assessing lesion response has also increased. The Liver Imaging Reporting and Data Systems (LI‐RADS) treatment response algorithm (LI‐RADS TRA) was created to standardize the assessment of response after locoregional therapy (LRT) on contrast‐enhanced CT or MRI. Originally created based on expert opinion, these guidelines are currently undergoing revision based on emerging evidence. While many studies support the use of LR‐TRA for evaluation of HCC response after thermal ablation and intra‐arterial embolic therapy, data suggest a need for refinements to improve assessment after radiation therapy. In this manuscript, we review expected MR imaging findings after different forms of LRT, clarify how to apply the current LI‐RADS TRA by type of LRT, explore emerging literature on LI‐RADS TRA, and highlight future updates to the algorithm.Evidence Level3.Technical EfficacyStage 2.
Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine
Lumish, Melissa , Thackray, Jennifer , Gian, Richard Kinh , Caudle, Kelly E. , Amstutz, Ursula , Schwab, Matthias , Diasio, Robert B. , Cercek, Andrea , Do, Richard Kinh Gian , Cercek, Andrea , Diasio, Robert B , Schwab, Matthias , Jarnagin, William R.

Mayo Clinic

JCO Precision Oncology | February 27, 2023 | Volume: No volume available | Issue: 7 | Pages: No page available

10.1200/po.22.00442 | PMID 36848609 Get It

A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC).
Tan, Benjamin , Reiss, Kim Anna, Mody, Kabir , Khalil, Daniel, Nadolski, G. , Giardina, Joseph Daniel , Capanu, Marinela , Bradley, Mikaela , Boussayoud, Chayma, Valentino, Emily , Harding, James J. , Erinjeri, Joseph P. , Yarmohammadi, Hooman , Gian, Richard Kinh , Merghoub, Taha , Jarnagin, William R. , Soulen, Michael C , Brown, Karen T. , Abou‐Alfa, Ghassan K.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS4146-TPS4146

10.1200/jco.2018.36.15_suppl.tps4146 Get It